These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 32479996)

  • 21. ApoE facilitates the microglial response to amyloid plaque pathology.
    Ulrich JD; Ulland TK; Mahan TE; Nyström S; Nilsson KP; Song WM; Zhou Y; Reinartz M; Choi S; Jiang H; Stewart FR; Anderson E; Wang Y; Colonna M; Holtzman DM
    J Exp Med; 2018 Apr; 215(4):1047-1058. PubMed ID: 29483128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microglia-specific ApoE knock-out does not alter Alzheimer's disease plaque pathogenesis or gene expression.
    Henningfield CM; Arreola MA; Soni N; Spangenberg EE; Green KN
    Glia; 2022 Feb; 70(2):287-302. PubMed ID: 34643971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accelerated microglial pathology is associated with Aβ plaques in mouse models of Alzheimer's disease.
    Baron R; Babcock AA; Nemirovsky A; Finsen B; Monsonego A
    Aging Cell; 2014 Aug; 13(4):584-95. PubMed ID: 24641683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Forebrain microglia from wild-type but not adult 5xFAD mice prevent amyloid-β plaque formation in organotypic hippocampal slice cultures.
    Hellwig S; Masuch A; Nestel S; Katzmarski N; Meyer-Luehmann M; Biber K
    Sci Rep; 2015 Sep; 5():14624. PubMed ID: 26416689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
    Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
    J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
    Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
    Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice.
    Zhao P; Xu Y; Fan X; Li L; Li X; Arase H; Tong Q; Zhang N; An Z
    MAbs; 2022; 14(1):2107971. PubMed ID: 35921534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease.
    Hanzel CE; Pichet-Binette A; Pimentel LS; Iulita MF; Allard S; Ducatenzeiler A; Do Carmo S; Cuello AC
    Neurobiol Aging; 2014 Oct; 35(10):2249-62. PubMed ID: 24831823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
    Katsouri L; Georgopoulos S
    PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia.
    Benitez DP; Jiang S; Wood J; Wang R; Hall CM; Peerboom C; Wong N; Stringer KM; Vitanova KS; Smith VC; Joshi D; Saito T; Saido TC; Hardy J; Hanrieder J; De Strooper B; Salih DA; Tripathi T; Edwards FA; Cummings DM
    Mol Neurodegener; 2021 Jul; 16(1):47. PubMed ID: 34266459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.
    Solberg NO; Chamberlin R; Vigil JR; Deck LM; Heidrich JE; Brown DC; Brady CI; Vander Jagt TA; Garwood M; Bisoffi M; Severns V; Vander Jagt DL; Sillerud LO
    J Alzheimers Dis; 2014; 40(1):191-212. PubMed ID: 24413613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease.
    Rodríguez JJ; Witton J; Olabarria M; Noristani HN; Verkhratsky A
    Cell Death Dis; 2010; 1(1):e1. PubMed ID: 21364611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia.
    Tsai AP; Lin PB; Dong C; Moutinho M; Casali BT; Liu Y; Lamb BT; Landreth GE; Oblak AL; Nho K
    Neurobiol Dis; 2021 Jun; 153():105303. PubMed ID: 33631273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microglial roles in Alzheimer's disease: An agent-based model to elucidate microglial spatiotemporal response to beta-amyloid.
    Weathered C; Bardehle S; Yoon C; Kumar N; Leyns CEG; Kennedy ME; Bloomingdale P; Pienaar E
    CPT Pharmacometrics Syst Pharmacol; 2024 Mar; 13(3):449-463. PubMed ID: 38078626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer's disease.
    Jury-Garfe N; Redding-Ochoa J; You Y; Martínez P; Karahan H; Chimal-Juárez E; Johnson TS; Zhang J; Resnick S; Kim J; Troncoso JC; Lasagna-Reeves CA
    Acta Neuropathol; 2024 Aug; 148(1):15. PubMed ID: 39102080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology.
    Samuels JD; Moore KA; Ennerfelt HE; Johnson AM; Walsh AE; Price RJ; Lukens JR
    Alzheimers Dement; 2023 Nov; 19(11):4908-4921. PubMed ID: 37061460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
    Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
    J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of transcriptome remodeling in plaque-associated and plaque-distant microglia during amyloid-β pathology progression in mice.
    Hemonnot-Girard AL; Meersseman C; Pastore M; Garcia V; Linck N; Rey C; Chebbi A; Jeanneteau F; Ginsberg SD; Lachuer J; Reynes C; Rassendren F; Hirbec H
    J Neuroinflammation; 2022 Sep; 19(1):234. PubMed ID: 36153535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuritic Plaques - Gateways to Understanding Alzheimer's Disease.
    Tsering W; Prokop S
    Mol Neurobiol; 2024 May; 61(5):2808-2821. PubMed ID: 37940777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.